CN110373587B - 一种骨诱导抗菌镁合金及其制备方法与应用 - Google Patents
一种骨诱导抗菌镁合金及其制备方法与应用 Download PDFInfo
- Publication number
- CN110373587B CN110373587B CN201910666812.2A CN201910666812A CN110373587B CN 110373587 B CN110373587 B CN 110373587B CN 201910666812 A CN201910666812 A CN 201910666812A CN 110373587 B CN110373587 B CN 110373587B
- Authority
- CN
- China
- Prior art keywords
- magnesium alloy
- magnesium
- silver
- antibacterial
- pure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910000861 Mg alloy Inorganic materials 0.000 title claims abstract description 84
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229910052709 silver Inorganic materials 0.000 claims abstract description 44
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 41
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 41
- 239000011777 magnesium Substances 0.000 claims abstract description 41
- 239000004332 silver Substances 0.000 claims abstract description 41
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229910052712 strontium Inorganic materials 0.000 claims abstract description 32
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000012535 impurity Substances 0.000 claims abstract description 26
- 238000010438 heat treatment Methods 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 239000000126 substance Substances 0.000 claims abstract description 18
- 238000005266 casting Methods 0.000 claims abstract description 13
- 238000005303 weighing Methods 0.000 claims abstract description 12
- 238000001816 cooling Methods 0.000 claims abstract description 10
- 239000000155 melt Substances 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- 239000000956 alloy Substances 0.000 claims description 31
- 229910045601 alloy Inorganic materials 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 230000001681 protective effect Effects 0.000 claims description 19
- 210000000988 bone and bone Anatomy 0.000 claims description 16
- 239000007789 gas Substances 0.000 claims description 16
- 230000002138 osteoinductive effect Effects 0.000 claims description 13
- 238000003723 Smelting Methods 0.000 claims description 12
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- 229910019015 Mg-Ag Inorganic materials 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 230000032683 aging Effects 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 229910018503 SF6 Inorganic materials 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 claims description 3
- 229960000909 sulfur hexafluoride Drugs 0.000 claims description 3
- 239000000203 mixture Substances 0.000 abstract description 7
- 230000004819 osteoinduction Effects 0.000 abstract description 4
- 238000006731 degradation reaction Methods 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 230000015556 catabolic process Effects 0.000 description 13
- 239000000463 material Substances 0.000 description 12
- 229910052751 metal Inorganic materials 0.000 description 10
- 238000001035 drying Methods 0.000 description 8
- 239000007943 implant Substances 0.000 description 8
- 238000002513 implantation Methods 0.000 description 8
- 239000002184 metal Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 5
- 229910000831 Steel Inorganic materials 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 229910010293 ceramic material Inorganic materials 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 239000011261 inert gas Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000005554 pickling Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- -1 stainless steel Chemical class 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- 230000033558 biomineral tissue development Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920006237 degradable polymer Polymers 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 238000005275 alloying Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 201000008968 osteosarcoma Diseases 0.000 description 2
- 239000013074 reference sample Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 208000025978 Athletic injury Diseases 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- VEQPNABPJHWNSG-UHFFFAOYSA-N Nickel(2+) Chemical compound [Ni+2] VEQPNABPJHWNSG-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 229910001430 chromium ion Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- SJCKRGFTWFGHGZ-UHFFFAOYSA-N magnesium silver Chemical compound [Mg].[Ag] SJCKRGFTWFGHGZ-UHFFFAOYSA-N 0.000 description 1
- SYJBLFMEUQWNFD-UHFFFAOYSA-N magnesium strontium Chemical compound [Mg].[Sr] SYJBLFMEUQWNFD-UHFFFAOYSA-N 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910001453 nickel ion Inorganic materials 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000004072 osteoblast differentiation Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000004537 potential cytotoxicity Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- 230000005476 size effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C1/00—Making non-ferrous alloys
- C22C1/02—Making non-ferrous alloys by melting
- C22C1/03—Making non-ferrous alloys by melting using master alloys
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C23/00—Alloys based on magnesium
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
- C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
- C22F1/06—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of magnesium or alloys based thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Metallurgy (AREA)
- Transplantation (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Thermal Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910666812.2A CN110373587B (zh) | 2019-07-23 | 2019-07-23 | 一种骨诱导抗菌镁合金及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910666812.2A CN110373587B (zh) | 2019-07-23 | 2019-07-23 | 一种骨诱导抗菌镁合金及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110373587A CN110373587A (zh) | 2019-10-25 |
CN110373587B true CN110373587B (zh) | 2020-11-10 |
Family
ID=68255116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910666812.2A Active CN110373587B (zh) | 2019-07-23 | 2019-07-23 | 一种骨诱导抗菌镁合金及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110373587B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112981200B (zh) * | 2021-02-08 | 2021-11-16 | 吉林大学 | 一种高密度亚结构镁合金、制备方法及其应用 |
CN113444943A (zh) * | 2021-06-22 | 2021-09-28 | 西安理工大学 | 一种具有抗菌、骨细胞增殖功能的镁合金及制备方法 |
CN113684407A (zh) * | 2021-08-30 | 2021-11-23 | 东莞理工学院 | 一种可降解Mg-Zn-Sr-Ag系镁合金及其制备方法与应用 |
CN114086045A (zh) * | 2021-10-11 | 2022-02-25 | 北京理工大学 | 一种降解速率可控的医用镁银合金的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012003502A2 (en) * | 2010-07-02 | 2012-01-05 | University Of Florida Research Foundation, Inc. | Bioresorbable metal alloy and implants made of same |
CN103120805A (zh) * | 2013-02-04 | 2013-05-29 | 中国科学院金属研究所 | 一种生物医用可降解镁合金的生物活性表面涂层及制备 |
CN104818414A (zh) * | 2015-03-19 | 2015-08-05 | 中国科学院金属研究所 | 一种具有多孔结构的金属植骨材料及其制备和应用 |
CN107435113A (zh) * | 2017-07-10 | 2017-12-05 | 太原理工大学 | 一种在生物体内可降解的高强韧耐腐蚀骨科用镁合金及其制备方法 |
CN109652768A (zh) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | 一种医用植入材料用镁-锶涂层及其制备方法 |
-
2019
- 2019-07-23 CN CN201910666812.2A patent/CN110373587B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012003502A2 (en) * | 2010-07-02 | 2012-01-05 | University Of Florida Research Foundation, Inc. | Bioresorbable metal alloy and implants made of same |
CN103120805A (zh) * | 2013-02-04 | 2013-05-29 | 中国科学院金属研究所 | 一种生物医用可降解镁合金的生物活性表面涂层及制备 |
CN104818414A (zh) * | 2015-03-19 | 2015-08-05 | 中国科学院金属研究所 | 一种具有多孔结构的金属植骨材料及其制备和应用 |
CN107435113A (zh) * | 2017-07-10 | 2017-12-05 | 太原理工大学 | 一种在生物体内可降解的高强韧耐腐蚀骨科用镁合金及其制备方法 |
CN109652768A (zh) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | 一种医用植入材料用镁-锶涂层及其制备方法 |
Non-Patent Citations (4)
Title |
---|
ANTIBACTERIAL BIODEGRADABLE Mg-Ag ALLOYS;Di Tie et al.;《European Cells and Materials》;20131231;第25卷;第284页 * |
Influence of the Microstructure and Silver Content on Degradation, Cytocompatibility, and Antibacterial Properties of Magnesium-Silver Alloys In Vitro;zhidan Liu et al.;《Oxidative Medicine and Cellular Longevity》;20170622;第2、4页 * |
The effect of osteoblasts on the surface oxidation processes of biodegradable Mg and Mg-Ag alloys studied by synchrotron IR microspectroscopy;Nezha Ahmad Agha et al.;《Materials Science & Engineering C》;20180605;第659-668页 * |
骨植入用新型可降解镁合金材料设计及生物医学功能研究;刘辰;《中国博士学位论文全文数据库工程科技Ⅰ辑》;20170615(第06期);第15、16、111、112页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110373587A (zh) | 2019-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110373587B (zh) | 一种骨诱导抗菌镁合金及其制备方法与应用 | |
JP6431957B2 (ja) | 生分解性金属合金 | |
US9863020B2 (en) | Biodegradable metal alloys | |
CN106086562B (zh) | 生物体内可降解吻合钉及其生产工艺 | |
CN108950336B (zh) | 一种高塑性可降解生物医用Mg-Zn-Zr-Ca-Fe合金材料及其制备方法 | |
CN102258806B (zh) | 一种可降解镁基骨科植入生物医用材料及制备方法 | |
CN112281027B (zh) | 一种可降解生物医用Zn-Cu-Ag-Zr系锌合金及其制备方法 | |
CN109966568A (zh) | 一种Zn-Ge-X三元生物医用材料及其制备方法 | |
CN108165782B (zh) | 一种医用锌基合金带材及其制备方法 | |
CN110951992B (zh) | 一种低弹性模量抗菌医用钛合金 | |
CN110656260B (zh) | 一种可降解医用Zn合金材料及其制备方法 | |
CN105803254B (zh) | 一种大块钛铜钙生物材料的制备方法 | |
CN108950443B (zh) | 一种具有抗菌和骨诱导活性功能的医用钛合金棒材 | |
CN109022853A (zh) | 一种抗菌Ti-Nb-Zr-Ag合金锭的制备方法 | |
Samudrala et al. | Preliminary biological evaluation of tantalum containing soda lime borosilicate bioactive glasses | |
CN108642359B (zh) | 一种高强度的快速降解生物医用Mg-Zn-Zr-Fe合金材料及其制备方法 | |
CN111218596A (zh) | 一种用于宫腔支架的短期可降解镁合金材料及制备方法 | |
EP4272774A1 (en) | Biodegradable magnesium alloy free of rare earth element, and preparation method and use thereof | |
CN113136503B (zh) | 一种生物医用TiNb基钛合金及其制备方法 | |
CN108913923B (zh) | 一种医用可降解Mg-Nd-Ag三元合金材料及其制备方法 | |
CN112192919B (zh) | 具有抗菌功能、可降解、强韧性的复合材料及其制备方法 | |
CN108425055B (zh) | 一种抗菌镁合金 | |
CN114231811A (zh) | 一种Mg-Nd-Zr-Sr-Sc-Sm生物可降解镁合金及其制备方法 | |
Takahashi et al. | Grindability and mechanical properties of experimental Ti–Au, Ti–Ag and Ti–Cu alloys | |
CN110669970A (zh) | 一种医用镁合金材料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500 Patentee after: Institute of health medicine, Guangdong Academy of Sciences Address before: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500 Patentee before: GUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231124 Address after: No.10, shiliugang Road, Haizhu District, Guangzhou City, Guangdong Province 510000 Patentee after: Institute of biological and medical engineering, Guangdong Academy of Sciences Address before: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500 Patentee before: Institute of health medicine, Guangdong Academy of Sciences |